Celgene collaborates with GlobeImmune
Clients Celgene International, Inc.
Jones Day advised Celgene International, Inc., a multinational biopharmaceutical company, in connection with its worldwide strategic collaboration with and related equity investment in GlobeImmune, Inc., a company focused on the discovery, development and commercialization of multiple product candidates based on targeted molecular immunotherapy for the treatment of cancer.